Can cell therapy help spinal-cord injury? A long-running study hopes the answer is yes.
Company pursues breakthrough medicines with proteins unlike any seen in nature.
But the technology for extinguishing species is dividing conservationists.
The blood-testing startup adds a flubbed test for the Zika virus to its rap sheet.
An antibody that clears up brain-destroying plaques may settle the cause of Alzheimer’s once and for all.
A key theory of blood dynamics has been overturned by video evidence showing how red blood cells can make blood less viscous.
The testing of new therapies to prevent a debilitating mitochondrial genetic disease in babies has hit a dead end.
Nobody understands the brain’s wiring diagram, but the tools of algebraic topology are beginning to tease it apart.
A novel solution for Parkinson’s patients who find their treatments wearing off.
A new technique called MAP-seq uses RNA bar codes to quickly and cheaply chart connections between brain cells.